Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000935836-26-000117·EcoR1 Capital, LLC
Schedule 13G ownership disclosure
Voyager Therapeutics Inc
Common Stock · CUSIP: 92915B106
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- EcoR1 Capital, LLC
Shares: 4,002,847.00 · Class: 6.8%
- Oleg Nodelman
Shares: 4,002,847.00 · Class: 6.8%
- EcoR1 Capital Fund Qualified, L.P.
Shares: 3,756,988.00 · Class: 6.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-26-000117
- Form type
- SCHEDULE 13G/A
- Filer
- EcoR1 Capital, LLC
- CIK
- CIK 1587114
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership